You are here
CERID Bibliography
.
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J Clin Invest. 2012 ;122(2):654-73.
An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection. J Virol. 2012 ;86(19):10587-96.
. Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses. Clin Exp Immunol. 2012 ;167(1):47-58.
. Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection. J Gen Virol. 2009 ;90(Pt 5):1153-63.
Doctor, why is my herpes so bad? The search continues. J Infect Dis. 2008 ;197(3):331-4.
. Herpes simplex: insights on pathogenesis and possible vaccines. Annu Rev Med. 2008 ;59:381-95.
. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J Virol. 2006 ;80(11):5509-15.
. Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman. J Clin Microbiol. 2006 ;44(4):1584-6.
. Vaccines for herpes simplex virus infections. Curr Opin Investig Drugs. 2006 ;7(2):136-41.
. Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor. Proc Natl Acad Sci U S A. 2003 ;100(22):12899-904.
. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev. 2003 ;16(1):96-113.
. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?. J Immunol. 2003 ;170(8):4380-8.
. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002 ;2(9):675-87.
. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis. 2001 ;33(6):885-90.
. .
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Ann Intern Med. 1998 ;128(1):21-8.
. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol. 1998 ;72(1):436-41.
. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat Med. 1998 ;4(4):381-2.
. .
.